Similar to our results, Liu et al. demonstrated that MRPL12 overexpression was related to worse survival rates in patients with breast cancer, while MRPL12 knockdown notably inhibited the proliferation and migration of breast cancer cells [11]. Here, MRPL12 is linked to breast cancer.